Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Completed

Whipple Protein Study

High-Protein Oral Nutritional Supplementation in Patients Undergoing Pancreaticoduodenectomy

Outcome
Finished, no results posted
Phase
No phase (not a drug trial)
Status
Completed
Study type
Interventional
Start
20 August 2019
Ended
15 November 2022
Enrollment
22 participants
Sites
1
Primary outcomes
Complications
Sponsor type
Academic / other
Results posted
No
Last update
7 May 2025

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

Study investigators aim to assess the effect of providing high-protein nutritional supplementation before and after surgery

Detailed description public domain (ClinicalTrials.gov)

Pancreaticoduodenectomy (PD) is a complex and morbid operation that is associated with many potential complications. Many people undergoing PD are malnourished due to their underlying medical condition or difficulties eating in the face of abdominal pain or obstruction from pancreatic disease. This study aims to assess the effect of high-protein dietary supplementation in improving perioperative nutrition and decreasing complications. We will randomize PD patients to an experimental arm in which they take a nutritional, high-protein supplement for 2 weeks before and after surgery, or to a control arm, where they will take a standard postoperative diet without supplementation. Outcomes and nutritional parameters will be examined after they complete the supplements.